Lead sponsor

Glostrup University Hospital, Copenhagen

2 GLP-1 and incretin trials led. Source: ClinicalTrials.gov, as of July 1, 2026.

2

Trials led

1

Active

134

Total enrollment

2

Sites

Distinct sites across this sponsor's lead trials. A site running several of them counts once, matching the map. Total enrollment sums each trial's reported enrollment, whether planned or actual.

Portfolio

How this sponsor's trials break down

Trials by phase

Phase 4
1
Not applicable
1

Trials by status

Recruiting
1
Completed
1

Trials led

ABSALONPh 4Recruiting126
-Oleoyl Glycerol is a GPR119 Agonist and Signals GLP-1 Release in Humans.Male · Healthy volunteersnot applicableCompleted8